Case details

Court: ded
Docket #: 1:15-cv-01030
Case Name: Dow Pharmaceutical Sciences, Inc. et al v. Tolmar, Inc.
PACER case #: 58200
Date filed: 2015-11-06
Date terminated: 2016-05-23
Assigned to: Judge Gregory M. Sleet
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
Dow Pharmaceutical Sciences, Inc.
Plaintiff
 
Jack B. Blumenfeld
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: jbbefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Valeant Pharmaceuticals North America LLC
Plaintiff
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED
Tolmar, Inc.
Defendant

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2015-11-06 1 0 COMPLAINT FOR PATENT INFRINGEMENT filed against Tolmar, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1823364.) - filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sec) (Entered: 11/06/2015) 2015-11-09 17:12:08 c51746426b708c5526649f0c6300304963876a07
1 1 Exhibit A-B
1 2 Civil Cover Sheet
2015-11-06 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 11/06/2015)
2015-11-06 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/25/2015. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 3/25/2018. (sec) (Entered: 11/06/2015)
2015-11-06 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,288,434 B2; 8,663,699 B2. (sec) (Entered: 11/06/2015)
2015-11-06 5 0 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International for Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC. (sec) (Entered: 11/06/2015)
2016-05-19 6 0 STATUS REPORT ORDER: Status Report due by 6/2/2016. Signed by Judge Gregory M. Sleet on 5/18/2016. (asw) (Entered: 05/19/2016)
2016-05-20 7 0 NOTICE of Voluntary Dismissal by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC (Blumenfeld, Jack) (Entered: 05/20/2016)
2016-05-25 8 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 05/25/2016)